|
End-of-day quote
Canadian Securities Exchange
08/09/2026
|
5-day change | 1st Jan Change | ||
| 0.0300 CAD | 0.00% |
|
+20.00% | -60.00% |
| Market Cap | 3.92M 2.85M 2.45M 2.3M 2.1M 270M 3.94M 27.29M 10.56M 138M 10.69M 10.46M 439M | P/E 2024 |
-1.85x | P/E 2025 | -3.69x |
|---|---|---|---|---|---|
| Enterprise Value | 5.43M 3.94M 3.39M 3.19M 2.91M 374M 5.46M 37.76M 14.61M 191M 14.79M 14.47M 608M | EV / Sales 2024 |
0.67x | EV / Sales 2025 | 0.89x |
| Free-Float |
85.31% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| HERB | End-of-day quote | |
Canadian Securities Exchange
| HERB | Delayed | |
|
OTC Markets
| LUFFF | Delayed | |
|
Deutsche Boerse AG
| HA9 | Delayed |
| 1 week | +20.00% | ||
| 1 month | -14.29% | ||
| 3 months | -45.45% | ||
| 6 months | -40.00% | ||
| Current year | -60.00% |
| 1 week | 0.02 |  | 0.04 |
| 1 month | 0.02 | | 0.04 |
| Current year | 0.02 | | 0.12 |
| 1 year | 0.02 | | 0.13 |
| 3 years | 0.02 | | 0.13 |
| 5 years | 0.02 | | 0.25 |
| 10 years | 0.02 | | 9.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Philip Campbell
CEO | Chief Executive Officer | - | 14/05/2020 |
Jason Vandenberg
DFI | Director of Finance/CFO | 49 | 17/01/2022 |
Aron Tegenfeldt
PRN | Corporate Officer/Principal | - | 31/07/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Herb Dhaliwal
CHM | Chairman | 73 | 22/04/2026 |
Philip Campbell
BRD | Director/Board Member | - | 14/05/2020 |
Drew Malcolm
BRD | Director/Board Member | - | 23/06/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/09/26 | Buy | Chairman | 100,000 | 0.0779% | ||
| 02/07/26 | Option | Executive/Senior Manager | -100,000 | 0.0779% | ||
| 02/07/26 | Option | Founder | 120,000 | 0.0935% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +20.00% | -50.00% | -70.00% | 2.85M | |
| +0.59% | +0.37% | -15.55% | -3.96% | 13.52B | |
| +0.74% | +1.42% | -31.79% | -55.48% | 4.98B | |
| -0.83% | -1.51% | -5.71% | -3.46% | 4.46B | |
| +0.82% | -0.94% | -6.69% | -27.67% | 3.96B | |
| +0.47% | +1.02% | -0.88% | +1.85% | 3.55B | |
| +0.37% | -1.38% | -24.95% | +6.77% | 3.54B | |
| -0.48% | -1.42% | -11.60% | +8.50% | 3.24B | |
| +0.20% | -1.40% | -23.66% | -14.07% | 2.33B | |
| +1.51% | -0.64% | -29.43% | -13.26% | 1.71B | |
| Average | +0.34% | +2.51% | -20.03% | -17.08% | 4.13B | |
| Weighted average by Cap. | +0.38% | +0.60% | -15.87% | -10.95% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 9.92M 7.2M 6.19M 5.83M 5.32M 683M 9.97M 69.04M 26.71M 349M 27.05M 26.46M 1.11B | 12.12M 8.8M 7.57M 7.12M 6.5M 834M 12.19M 84.35M 32.63M 426M 33.05M 32.33M 1.36B |
| Net income | -2.77M -2.01M -1.73M -1.63M -1.49M -191M -2.79M -19.29M -7.46M -97.54M -7.56M -7.39M -310M | -1.84M -1.34M -1.15M -1.08M -987K -127M -1.85M -12.81M -4.96M -64.77M -5.02M -4.91M -206M |
| Net Debt | 1.37M 998K 858K 807K 737K 94.62M 1.38M 9.57M 3.7M 48.36M 3.75M 3.67M 154M | 1.51M 1.09M 940K 884K 807K 104M 1.51M 10.47M 4.05M 52.96M 4.1M 4.01M 169M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/09/26 | CA$0.0300 | 0.00% | 113,000 |
| 04/09/26 | CA$0.0300 | 0.00% | 73,350 |
| 03/09/26 | CA$0.0300 | 0.00% | 64,857 |
| 02/09/26 | CA$0.0300 | +20.00% | 45,610 |
| 01/09/26 | CA$0.0250 | -16.67% | 159,032 |
- Stock Market
- Stocks
- HERB Stock
Select your edition
All financial news and data tailored to specific country editions
